Macellum Opportunity Fund LP 4

Accession 0000921895-20-001113

CIK 0000768835other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 6:27 PM ET

Size

18.1 KB

Accession

0000921895-20-001113

Form 4

Period: 2020-04-13

Director

Transactions

Exercise of In-Money
Common Stock $0.01 par value
2020-04-14$17.50/sh+73,500$1,286,250→ 926,612 total(indirect: See Footnote)
Sale
Call Options (right to buy)
2020-04-14$1.67/sh−840$1,405→ 73,500 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (84,000 underlying)
Exercise of In-Money
Call Options (right to buy)
2020-04-14−735→ 0 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (73,500 underlying)
Sale
Call Options (right to buy)
2020-04-13$1.85/sh−675$1,246→ 157,500 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (67,500 underlying)

Other

Transactions

Exercise of In-Money
Common Stock $0.01 par value
2020-04-14$17.50/sh+73,500$1,286,250→ 926,612 total(indirect: See Footnote)
Sale
Call Options (right to buy)
2020-04-13$1.85/sh−675$1,246→ 157,500 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (67,500 underlying)
Exercise of In-Money
Call Options (right to buy)
2020-04-14−735→ 0 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (73,500 underlying)
Sale
Call Options (right to buy)
2020-04-14$1.67/sh−840$1,405→ 73,500 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (84,000 underlying)

Other

Transactions

Sale
Call Options (right to buy)
2020-04-14$1.67/sh−840$1,405→ 73,500 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (84,000 underlying)
Exercise of In-Money
Common Stock $0.01 par value
2020-04-14$17.50/sh+73,500$1,286,250→ 926,612 total(indirect: See Footnote)
Sale
Call Options (right to buy)
2020-04-13$1.85/sh−675$1,246→ 157,500 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (67,500 underlying)
Exercise of In-Money
Call Options (right to buy)
2020-04-14−735→ 0 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (73,500 underlying)

Other

Transactions

Sale
Call Options (right to buy)
2020-04-13$1.85/sh−675$1,246→ 157,500 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (67,500 underlying)
Exercise of In-Money
Common Stock $0.01 par value
2020-04-14$17.50/sh+73,500$1,286,250→ 926,612 total(indirect: See Footnote)
Exercise of In-Money
Call Options (right to buy)
2020-04-14−735→ 0 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (73,500 underlying)
Sale
Call Options (right to buy)
2020-04-14$1.67/sh−840$1,405→ 73,500 total(indirect: See Footnote)
Exercise: $17.50From: 2020-03-02Exp: 2020-04-17→ Common Stock $0.01 par value (84,000 underlying)

Footnotes (2)

[F1]This Form 4 is filed jointly by Macellum Opportunity Fund LP ("Macellum Opportunity"), Macellum Management, LP ("Macellum Management"), Macellum Advisors GP, LLC ("Macellum GP") and Jonathan Duskin (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously owned more than 10% of the Issuer's outstanding shares of Common Stock, par value $0.01 (the "Common Stock"). As of April 14, 2020, the Reporting Persons ceased to own in the aggregate more than 10% of the Issuer's outstanding Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
[F2]Securities owned directly by Macellum Opportunity. As the investment manager of Macellum Opportunity, Macellum Management may be deemed to beneficially own the securities owned directly by Macellum Opportunity. As the general partner of Macellum Opportunity, Macellum GP may be deemed to beneficially own securities owned directly by Macellum Opportunity. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities owned directly by Macellum Opportunity.

Documents

1 file

BIG LOTS INC

CIK 0000768835

Entity typeother